About Brenus Pharma
Brenus Pharma is a company based in Issoire (France) founded in 2020.. Brenus Pharma has raised $25 million across 1 funding round from investors including Crédit Agricole, Angelor and UI Investissement. Brenus Pharma offers products and services including STC 1010 and STC Platform. Brenus Pharma operates in a competitive market with competitors including IGM Biosciences, Imvax, Check-Cap, BriaCell Therapeutics and New Element Medicine, among others.
- Headquarter Issoire, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25 M (USD)
in 1 rounds
-
Latest Funding Round
$25 M (USD), Series A
Sep 18, 2024
-
Investors
Crédit Agricole
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Brenus Pharma
Brenus Pharma offers a comprehensive portfolio of products and services, including STC 1010 and STC Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Immunotherapy targeting colorectal cancer to educate immune system against relapse.
Allogeneic system generating tumor antigen-focused treatments for solid tumors.
Unlock access to complete
Unlock access to complete
Funding Insights of Brenus Pharma
Brenus Pharma has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series A round of $25 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $25.0M
-
First Round
First Round
(18 Sep 2024)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - Brenus Pharma | Valuation | Angelor |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Brenus Pharma
Brenus Pharma has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Crédit Agricole, Angelor and UI Investissement. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UI Investissement is engaged in private equity and investment services.
|
Founded Year | Domain | Location | |
|
Noshaq is recognized as a Liège-based investment fund providing financing solutions.
|
Founded Year | Domain | Location | |
|
Investsud is engaged in supporting SMEs with sustainable investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Brenus Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Brenus Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Brenus Pharma Comparisons
Competitors of Brenus Pharma
Brenus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IGM Biosciences, Imvax, Check-Cap, BriaCell Therapeutics and New Element Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibodies for cancer and infectious disease treatments are developed.
|
|
| domain | founded_year | HQ Location |
Patient-specific cell vaccines for glioma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of imaging capsules for colorectal cancer screening
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
Drugs for cancer and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for multiple diseases are developed using Aminoacyl-tRNA Synthetase technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Brenus Pharma
When was Brenus Pharma founded?
Brenus Pharma was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Where is Brenus Pharma located?
Brenus Pharma is headquartered in Issoire, France. It is registered at Issoire, Auvergne-rhone-alpes, France.
Who is the current CEO of Brenus Pharma?
Jacques Gardette is the current CEO of Brenus Pharma.
Is Brenus Pharma a funded company?
Brenus Pharma is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Series A of $25M, raised on Sep 18, 2024.
What does Brenus Pharma do?
Brenus Pharma was founded in 2020 in Issoire, France, where focus is placed on biotechnology for oncology. Immunotherapy solutions are developed, with STC-1010 targeted at metastatic colorectal cancer and other solid tumors. Operations center on advancing clinical-stage treatments within the pharmaceutical sector, supporting research and development for cancer therapies across Europe.
Who are the top competitors of Brenus Pharma?
Brenus Pharma's top competitors include Imvax, IGM Biosciences and Check-Cap.
What products or services does Brenus Pharma offer?
Brenus Pharma offers STC 1010 and STC Platform.
Who are Brenus Pharma's investors?
Brenus Pharma has 5 investors. Key investors include Crédit Agricole, Angelor, UI Investissement, Noshaq, and Investsud.